Cargando…
The growing pains of ifosfamide
Ifosfamide is a commonly used chemotherapeutic known to have numerous adverse kidney manifestations. In this issue of Clinical Kidney Journal, Ensergueix et al. report a multicentric observational retrospective French study on 34 adult patients with tubular dysfunction and /or kidney dysfunction fol...
Autores principales: | Sprangers, Ben, Lapman, Sebastian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7467579/ https://www.ncbi.nlm.nih.gov/pubmed/32897272 http://dx.doi.org/10.1093/ckj/sfaa017 |
Ejemplares similares
-
‘Prevention is better than cure’: warning for comedications in patients receiving immune checkpoint inhibitors to avoid acute kidney injury
por: Belliere, Julie, et al.
Publicado: (2022) -
Pseudo-AKI associated with targeted anti-cancer agents—the truth is in the eye of the filtration marker
por: Vanhoutte, Thomas, et al.
Publicado: (2023) -
Tyrosine kinase inhibitor-induced hypertension—marker of anti-tumour treatment efficacy or cardiovascular risk factor?
por: Ptinopoulou, Anastasia G., et al.
Publicado: (2020) -
Checkpoint inhibitor therapy-associated acute kidney injury: time to move on to evidence-based recommendations
por: Perazella, Mark A, et al.
Publicado: (2021) -
Testing the functional reserve of the kidney before hematopoietic stem cell transplantation: doubt remains
por: De Moor, Bart, et al.
Publicado: (2023)